Los Angeles Capital Management’s NovoCure NVCR Stock Holding History

Los Angeles Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	+78,006	New	+$1.18M	﹤0.01%	704
2026 Q1	–	Sell	-35	Closed	-$449	–	2541
2025 Q4	$449	Buy	+35	New	+$449	﹤0.01%	2492
2025 Q3	–	Sell	-33,122	Closed	-$590K	–	1480
2025 Q2	$590K	Sell	33,122 -22,676	-41%	-$395K	﹤0.01%	807
2025 Q1	$994K	Sell	55,798 -14,803	-21%	-$336K	﹤0.01%	566
2024 Q4	$2.1M	Buy	70,601 +55,334	+362%	+$1.17M	0.01%	440
2024 Q3	$239K	Buy	+15,267	New	+$277K	﹤0.01%	1080
2021 Q3	–	Sell	-1,529	Closed	-$339K	–	1557
2021 Q2	$339K	Sell	1,529 -5,829	-79%	-$1.13M	﹤0.01%	1347
2021 Q1	$973K	Sell	7,358 -20,095	-73%	-$3.18M	﹤0.01%	908
2020 Q4	$4.75M	Sell	27,453 -21,515	-44%	-$2.94M	0.02%	405
2020 Q3	$5.45M	Sell	48,968 -145,955	-75%	-$11.7M	0.03%	349
2020 Q2	$11.6M	Buy	194,923 +138,595	+246%	+$9.12M	0.06%	252
2020 Q1	$3.79M	Buy	56,328 +35,545	+171%	+$2.81M	0.02%	388
2019 Q4	$1.75M	Buy	20,783 +11,518	+124%	+$930K	0.01%	680
2019 Q3	$693K	Sell	9,265 -12,534	-57%	-$1M	﹤0.01%	904
2019 Q2	$1.38M	Buy	21,799 +500	+2%	+$25.3K	0.01%	742
2019 Q1	$1.03M	Buy	+21,299	New	+$1.03M	0.01%	848
2018 Q4	–	Sell	-36,244	Closed	-$1.9M	–	1346
2018 Q3	$1.9M	Hold	36,244	–	–	0.01%	679
2018 Q2	$1.13M	Buy	+36,244	New	+$1.01M	0.01%	854

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Los Angeles Capital Management's NVCR Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in NovoCure (NVCR) in Q2 2026: 78,006 shares worth $1.18M. The stake represents ﹤0.01% of the portfolio and ranks #704 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in NVCR as recently as Q4 2025.

Los Angeles Capital Management first reported a position in NVCR in Q2 2018 and has held it in 18 quarters since. The position peaked at $11.6M in Q2 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Los Angeles Capital Management held 78,006 shares of NovoCure worth $1.18M as of Q2 2026.
NovoCure was a new Los Angeles Capital Management position in Q2 2026.
NovoCure made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #704 holding.
Los Angeles Capital Management first reported a position in NovoCure in Q2 2018 and has held it in 18 quarters since.
Los Angeles Capital Management's NovoCure position peaked at $11.6M in Q2 2020.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.